Japanese Society for Palliative Medicine
News Letter No.63
May 2014  63
Journal Watch
東北大学大学院緩和ケア看護学分野  佐藤 一樹
(レビュー担当:宮下 光令、佐藤 一樹、清水 恵)



【N Engl J Med. 2013;369(23-26), 2014;370(1-9)】

【Lancet. 2013; 382(9908-9910), 2014; 383(9911-9918)】
看取りのクリニカルパスLiverpool Care Pathwayの有効性を検証した

Costantini M, Romoli V, Leo SD, Beccaro M, Bono L, Pilastri P, Miccinesi G, Valenti D, Peruselli C, Bulli F, Franceschini C, Grubich S, Brunelli C, Martini C, Pellegrini F, Higginson IJ, Liverpool Care Pathway Italian Cluster Trial Study G. Liverpool Care Pathway for patients with cancer in hospital: a cluster randomised trial. Lancet.2014;383(9913):226-37.

【Lancet Oncol. 2013;14(13), 2014;15(1-2)】

【JAMA. 2013;310(21-24), 2014;311(1-8)】

Curtis JR, Back AL, Ford DW, Downey L, Shannon SE, Doorenbos AZ, Kross EK, Reinke LF, Feemster LC, Edlund B, Arnold RW, O'Connor K, Engelberg RA. Eff ect of communication skills training for residents and nurse practitioners on quality of communication with patients with serious illness: a randomized trial. JAMA. 2013;310(21):2271-81.

【JAMA Intern Med. 2013;73(22), 2014;174(1-2)】

Goldfeld KS, Grabowski DC, Caudry DJ, Mitchell SL. Health insurance status and the care of nursing home residents with advanced dementia. JAMA Intern Med. 2013;173(22):2047-53.

Walling AM, Tisnado D, Asch SM, Malin JM, Pantoja P, Dy SM, Ettner SL, Zisser AP, Schreibeis-Baum H, Lee M,Lorenz KA. The quality of supportive cancer care in the veterans aff airs health system and targets for improvement.JAMA Intern Med. 2013;173(22):2071-9.

【BMJ. 2013;347(7936-7938), 2014;348(7939-7943)】

Jena AB, Goldman D, Weaver L, Karaca-Mandic P. Opioid prescribing by multiple providers in Medicare:retrospective observational study of insurance claims. BMJ. 2014;348:g1393.

【Ann Intern Med. 2013;159(11-12), 2014;160(1-4)】

Suh E, Daugherty CK, Wroblewski K, Lee H, Kigin ML, Rasinski KA, Ford JS, Tonorezos ES, Nathan PC, Oeffi nger KC, Henderson TO. General Internists’ Preferences and Knowledge About the Care of Adult Survivors of Childhood Cancer: A Cross-sectional Survey. Ann Intern Med. 2014;160(1):11-7.

Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, Chou R. Opioid Prescribing: A Systematic Review and Critical Appraisal of Guidelines for Chronic Pain. Ann Intern Med. 2014;160(1):38-47.

【J Clin Oncol. 2013; 31(34-36), 2014; 32(1-6)】
化学療法による好中球減少症に対するG-CSF の予防的投与を比較した無作為化比較試験

Aarts MJ, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van
Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW,Temizkan M, Batman E, Muller EW, van Gastel SM, Borm GF, Tjan-Heijnen VC. Primary granulocyte colonystimulating factor prophylaxis during the fi rst two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia. J Clin Oncol. 2013;31(34):4290-6.

Ness KK, Krull KR, Jones KE, Mulrooney DA, Armstrong GT, Green DM, Chemaitilly W, Smith WA, Wilson CL,Sklar CA, Shelton K, Srivastava DK, Ali S, Robison LL, Hudson MM. Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study. J Clin Oncol.2013;31(36):4496-503.

Wagner EH, Ludman EJ, Aiello Bowles EJ, Penfold R, Reid RJ, Rutter CM, Chubak J, McCorkle R. Nurse navigators in early cancer care: a randomized, controlled trial. J Clin Oncol. 2014;32(1):12-8.

Kenis C, Decoster L, Van Puyvelde K, De Greve J, Conings G, Milisen K, Flamaing J, Lobelle JP, Wildiers H.Performance of two geriatric screening tools in older patients with cancer. J Clin Oncol. 2014;32(1):19-26.

Roila F, Ruggeri B, Ballatori E, Del Favero A, Tonato M. Aprepitant versus dexamethasone for preventing chemotherapy-induced delayed emesis in patients with breast cancer: a randomized double-blind study. J Clin Oncol.2014;32(2):101-6.

Traeger L, Cannon S, Keating NL, Pirl WF, Lathan C, Martin MY, He Y, Park ER. Race by sex differences in depression symptoms and psychosocial service use among non-Hispanic black and white patients with lung cancer. J Clin Oncol. 2014;32(2):107-13.

ASCO special article:2013年のがん医療の進展
Patel JD, Krilov L, Adams S, Aghajanian C, Basch E, Brose MS, Carroll WL, de Lima M, Gilbert MR, Kris MG, Marshall JL, Masters GA, O'Day SJ, Polite B, Schwartz GK, Sharma S, Thompson I, Vogelzang NJ, Roth BJ. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.J Clin Oncol. 2014;32(2):129-60.

WEB によるがん患者の症状評価・教育ツールに関する無作為化比較試験
Berry DL, Hong F, Halpenny B, Partridge AH, Fann JR, Wolpin S, Lober WB, Bush NE, Parvathaneni U, Back AL, Amtmann D, Ford R. Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. J Clin Oncol. 2014;32(3):199-205.

Engelhardt EG, Garvelink MM, de Haes JH, van der Hoeven JJ, Smets EM, Pieterse AH, Stiggelbout AM. Predicting and communicating the risk of recurrence and death in women with early-stage breast cancer: a systematic review of risk prediction models. J Clin Oncol. 2014;32(3):238-50.

Zhao F, Chang VT, Cleeland C, Cleary JF, Mitchell EP, Wagner LI, Fisch MJ. Determinants of Pain Severity Changes in Ambulatory Patients With Cancer: An Analysis From Eastern Cooperative Oncology Group Trial E2Z02.J Clin Oncol. 2014;32(4):312-9.

Gardner JR, Livingston PM, Fraser SF. Eff ects of exercise on treatment-related adverse eff ects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol. 2014;32(4):335-46.

Soneji S, Beltran-Sanchez H, Sox HC. Assessing progress in reducing the burden of cancer mortality, 1985-2005. J Clin Oncol. 2014;32(5):444-8.

Garland SN, Carlson LE, Stephens AJ, Antle MC, Samuels C, Campbell TS. Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized,partially blinded, noninferiority trial. J Clin Oncol. 2014;32(5):449-57.

【Ann Oncol. 2013;24(12), 2014;25(1-2)】

Alberti P, Rossi E, Cornblath DR, Merkies IS, Postma TJ, Frigeni B, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galie E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG, Cavaletti G, Group CI-P. Physicianassessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Ann Oncol. 2014;25(1):257-64.

カルボプラチン・パクリタキセル療法の1 週投与と3 週投与でのQOLの比較:子宮がん対象の第V相試験から
Harano K, Terauchi F, Katsumata N, Takahashi F, Yasuda M, Takakura S, Takano M, Yamamoto Y, Sugiyama T.Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II-IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016). Ann Oncol. 2014;25(1):251-7.

ソラフェニブに関連した腎がんの手足症候群に対する低摩擦性のセラミド配合ハイドロコロイドドレッシング材の効果を検証した無作為 化比較試験
Shinohara N, Nonomura N, Eto M, Kimura G, Minami H, Tokunaga S, Naito S. A randomized multicenter phase II trial on the effi cacy of a hydrocolloid dressing containing ceramide with a low-friction external surface for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinoma. Ann Oncol. 2014;25(2):472-6.

Ben-Arye E, Massalha E, Bar-Sela G, Silbermann M, Agbarya A, Saad B, Lev E, Schiff E. Stepping from traditional to integrative medicine: perspectives of Israeli-Arab patients on complementary medicine's role in cancer care. Ann Oncol. 2014;25(2):476-80.

Bozzetti F, Santarpia L, Pironi L, Thul P, Klek S, Gavazzi C, Tinivella M, Joly F, Jonkers C, Baxter J, Gramlich L, Chicharro L, Staun M, Van Gossum A, Lo Vullo S, Mariani L. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann Oncol.2014;25(2):487-93.

リンパ腫患者での化学療法中の運動プログラムによる治療関連の副作用やQOL に対する効果を検証した無作為化比較試験
Streckmann F, Kneis S, Leifert JA, Baumann FT, Kleber M, Ihorst G, Herich L, Grussinger V, Gollhofer A, Bertz H.Exercise program improves therapy-related side-eff ects and quality of life in lymphoma patients undergoing therapy.Ann Oncol. 2014;25(2):493-9.

【Eur J Cancer. 2013;49(18), 2014;50(1-3)】

【Br J Cancer. 2013;109(11-12), 2014;110(1-4)】

van der Meulen IC, May AM, de Leeuw JR, Koole R, Oosterom M, Hordijk GJ, Ros WJ. Long-term eff ect of a nurseled psychosocial intervention on health-related quality of life in patients with head and neck cancer: a randomised controlled trial. Br J Cancer. 2014;110(3):593-601.

【Cancer. 2013;119(23-24), 2014;120(1-4)】

Buff art LM, Galvao DA, Chinapaw MJ, Brug J, Taaff e DR, Spry N, Joseph D, Newton RU. Mediators of the resistance and aerobic exercise intervention eff ect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer. Cancer. 2014;120(2):294-301.

El-Jawahri A, Traeger L, Park ER, Greer JA, Pirl WF, Lennes IT, Jackson VA, Gallagher ER, Temel JS. Associations among prognostic understanding, quality of life, and mood in patients with advanced cancer. Cancer. 2014;120(2):278-85.

様々ながん腫でのQOL・症状による予後予測:EORTC QLQ-C30を用いた無作為化比較試験データの2次分析
Quinten C, Martinelli F, Coens C, Sprangers MA, Ringash J, Gotay C, Bjordal K, Greimel E, Reeve BB, Maringwa J, Ediebah DE, Zikos E, King MT, Osoba D, Taphoorn MJ, Flechtner H, Schmucker-Von Koch J, Weis J, Bottomley A, Patient Reported O, Behavioral E, the European Organization for R, Treatment of Cancer Clinical G. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in diff erent tumor sites. Cancer. 2014;120(2):302-11.

Wikman A, Johar A, Lagergren P. Presence of symptom clusters in surgically treated patients with esophageal cancer: implications for survival. Cancer. 2014;120(2):286-93.

外来がん患者の倦怠感の1 ヶ月間での急激な悪化の予測因子
Fisch MJ, Zhao F, O'Mara AM, Wang XS, Cella D, Cleeland CS. Predictors of significant worsening of patientreported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors. Cancer. 2014;120(3):442-50.